GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Net-Net Working Capital

Invitro International (Invitro International) Net-Net Working Capital : $0.02 (As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Invitro International's Net-Net Working Capital for the quarter that ended in Jun. 2097 was $0.02.

The industry rank for Invitro International's Net-Net Working Capital or its related term are showing as below:

IVRO's Price-to-Net-Net-Working-Capital is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 5.635
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Invitro International Net-Net Working Capital Historical Data

The historical data trend for Invitro International's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International Net-Net Working Capital Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
Net-Net Working Capital
Get a 7-Day Free Trial -0.14 0.21 0.18 0.08 0.08

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.08 - 0.04 0.02

Competitive Comparison of Invitro International's Net-Net Working Capital

For the Diagnostics & Research subindustry, Invitro International's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitro International's Price-to-Net-Net-Working-Capital Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Invitro International's Price-to-Net-Net-Working-Capital falls into.



Invitro International Net-Net Working Capital Calculation

Invitro International's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Sep. 2096 is calculated as

Net-Net Working Capital(A: Sep. 2096 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.2+0.75 * 0+0.5 * 0.4-0.3
-0-0)/13.228
=0.08

Invitro International's Net-Net Working Capital (NNWC) per share for the quarter that ended in Jun. 2097 is calculated as

Net-Net Working Capital(Q: Jun. 2097 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.169+0.75 * 0.175+0.5 * 0.486-0.193
-0-0)/14.028
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Invitro International  (OTCPK:IVRO) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Invitro International Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Invitro International's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitro International (Invitro International) Business Description

Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.